Wright Medical Group N.V. (WMGI) Financial Statements (2025 and earlier)

Company Profile

Business Address PRINS BERNHARDPLEIN 200
AMSTERDAM, 1097JB
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments    147,263150,574161,516
Cash and cash equivalents    147,263150,574161,516
Receivables107,701125,393147,400137,411139,680138,666
Inventory, net of allowances, customer advances and progress billings238,783215,797198,374197,283194,720186,910
Inventory238,783215,797198,374197,283194,720186,910
Prepaid expense14,84715,57016,03117,46014,22514,436
Other current assets212,121188,926214,997141,347280,343308,955
Other undisclosed current assets133,651102,837166,856   
Total current assets:707,103648,523743,658640,764779,542810,483
Noncurrent Assets
Property, plant and equipment259,313257,609251,922233,494239,734233,368
Intangible assets, net (including goodwill)1,505,8851,504,0641,518,3491,517,3271,537,4901,540,749
Goodwill1,262,2961,255,2231,260,9671,254,3041,263,9581,262,525
Intangible assets, net (excluding goodwill)243,589248,841257,382263,023273,532278,224
Deferred income tax assets991     
Other noncurrent assets90,23569,42470,699116,324204,970243,815
Other undisclosed noncurrent assets  9621,012923948933
Total noncurrent assets:1,856,4241,832,0591,841,9821,868,0681,983,1422,018,865
TOTAL ASSETS:2,563,5272,480,5822,585,6402,508,8322,762,6842,829,348
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities406,878387,590419,146318,342439,055478,994
Accounts payable36,16243,92132,12135,65143,94944,471
Accrued liabilities370,716343,669387,025282,691395,106434,523
Debt454,337379,514430,862425,312417,911410,311
Total current liabilities:861,215767,104850,008743,654856,966889,305
Noncurrent Liabilities
Long-term debt and lease obligation, including:756,829742,594737,167731,756727,348721,719
Capital lease obligations19,32420,80920,476
Other undisclosed long-term debt and lease obligation756,829742,594737,167712,432706,539701,243
Liabilities, other than long-term debt104,56081,52496,288181,502272,340305,069
Deferred tax liabilities, net10,78511,72912,293
Deferred income tax liabilities9,914     
Other liabilities94,64681,52496,288170,717260,611292,776
Other undisclosed noncurrent liabilities  10,00210,384   
Total noncurrent liabilities:861,389834,120843,839913,258999,6881,026,788
Total liabilities:1,722,6041,601,2241,693,8471,656,9121,856,6541,916,093
Equity
Equity, attributable to parent840,923879,358891,793851,920906,030913,255
Common stock4,7064,6974,6914,6344,6234,608
Additional paid in capital2,630,1942,620,5162,608,9392,563,3972,553,4422,542,747
Accumulated other comprehensive loss(27,340)(38,611)(29,499)(39,796)(19,509)(19,386)
Accumulated deficit(1,766,637)(1,707,244)(1,692,338)(1,676,315)(1,632,526)(1,614,714)
Total equity:840,923879,358891,793851,920906,030913,255
TOTAL LIABILITIES AND EQUITY:2,563,5272,480,5822,585,6402,508,8322,762,6842,829,348

Income Statement (P&L) ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Revenues129,955218,540248,605212,434229,734230,127
Revenue, net230,127
Cost of revenue
(Cost of Goods and Services Sold)
(28,723)(38,915)(49,545)(44,441)(48,338)(46,317)
Gross profit:101,232179,625199,060167,993181,396183,810
Operating expenses(140,510)(182,313)(184,944)(179,133)(178,730)(177,865)
Operating income (loss):(39,278)(2,688)14,116(11,140)2,6665,945
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
7,46213,7072,477(1,317)1,831(12,895)
Other undisclosed loss from continuing operations before equity method investments, income taxes(21,176)(20,470)(20,711)(20,448)(19,995)(19,695)
Loss from continuing operations before income taxes:(52,992)(9,451)(4,118)(32,905)(15,498)(26,645)
Income tax expense (benefit)11(2,138)(2,628)(3,295)(3,434)(3,611)
Loss from continuing operations:(52,981)(11,589)(6,746)(36,200)(18,932)(30,256)
Loss before gain (loss) on sale of properties:(52,981)(11,589)(6,746)(36,200)(18,932)(30,256)
Net loss:(52,981)(11,589)(6,746)(36,200)(18,932)(30,256)
Other undisclosed net income (loss) attributable to parent(6,412)(3,317)(9,277)(7,589)1,120(6,345)
Net loss available to common stockholders, diluted:(59,393)(14,906)(16,023)(43,789)(17,812)(36,601)

Comprehensive Income ($ in thousands)

9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Net loss:(52,981)(11,589)(6,746)(36,200)(18,932)(30,256)
Other comprehensive income (loss) 11,271(9,112)10,297(20,287)(123)(11,303)
Comprehensive income (loss):(41,710)(20,701)3,551(56,487)(19,055)(41,559)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,412)(3,317)(9,277)(7,589)1,120(6,345)
Comprehensive income (loss), net of tax, attributable to parent:(48,122)(24,018)(5,726)(64,076)(17,935)(47,904)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: